...
首页> 外文期刊>Molecular cell >Replication Fork Slowing and Reversal upon DNA Damage Require PCNA Polyubiquitination and ZRANB3 DNA Translocase Activity
【24h】

Replication Fork Slowing and Reversal upon DNA Damage Require PCNA Polyubiquitination and ZRANB3 DNA Translocase Activity

机译:DNA损伤后复制叉减速和逆转需要PCNA多覆和ZranB3 DNA易位酶活性

获取原文
获取原文并翻译 | 示例
           

摘要

DNA damage tolerance during eukaryotic replication is orchestrated by PCNA ubiquitination. While monoubiquitination activates mutagenic translesion synthesis, polyubiquitination activates an error-free pathway, elusive in mammals, enabling damage bypass by template switching. Fork reversal is driven in vitro by multiple enzymes, including the DNA translocase ZRANB3, shown to bind polyubiquitinated PCNA. However, whether this interaction promotes fork remodeling and template switching in vivo was unknown. Here we show that damage-induced fork reversal in mammalian cells requires PCNA ubiquitination, UBC13, and K63-linked polyubiquitin chains, previously involved in error-free damage tolerance. Fork reversal in vivo also requires ZRANB3 translocase activity and its interaction with polyubiquitinated PCNA, pinpointing ZRANB3 as a key effector of error-free DNA damage tolerance. Mutations affecting fork reversal also induced unrestrained fork progression and chromosomal breakage, suggesting fork remodeling as a global fork slowing and protection mechanism. Targeting these fork protection systems represents a promising strategy to potentiate cancer chemotherapy.
机译:通过PCNA ubiquitination策划了真核复制期间的DNA损伤耐受性。虽然单次素化激活致突变性的转源合成,但多沸基激活无差错的途径,在哺乳动物中难以捉摸,从而通过模板切换使绕道绕过绕过绕过。叉逆转通过多种酶在体外驱动,包括DNA易位蛋白酶ZranB3,所示为粘合多氮化PCNA。但是,这种相互作用是否促进叉重塑和模板切换的体内未知。在这里,我们表明哺乳动物细胞中的损伤诱导的叉逆转需要PCNA泛素,UBC13和K63连接的多掺子粘蛋白链,以前参与无差错损伤耐受性。体内叉逆转还需要ZranB3译式酶活性及其与多聚泛络PCNA的相互作用,将ZranB3定位为无差无差DNA损伤耐受性的关键效应器。影响叉逆转的突变也诱导无拘无束的叉进展和染色体破裂,表明叉重塑作为全球叉减速和保护机制。定位这些叉保护系统代表了有希望的癌症化疗的有希望的策略。

著录项

  • 来源
    《Molecular cell》 |2017年第5期|共14页
  • 作者单位

    Univ Zurich Inst Mol Canc Res CH-8057 Zurich Switzerland;

    Univ Zurich Inst Mol Canc Res CH-8057 Zurich Switzerland;

    Univ Zurich Inst Mol Canc Res CH-8057 Zurich Switzerland;

    Univ Zurich Inst Mol Canc Res CH-8057 Zurich Switzerland;

    Univ Zurich Inst Mol Canc Res CH-8057 Zurich Switzerland;

    Univ Zurich Inst Mol Canc Res CH-8057 Zurich Switzerland;

    Columbia Univ Irving Med Ctr Irving Canc Res Dept Genet &

    Dev New York NY 10032 USA;

    Columbia Univ Irving Med Ctr Irving Canc Res Dept Genet &

    Dev New York NY 10032 USA;

    Vanderbilt Univ Sch Med Dept Biochem Nashville TN 37205 USA;

    Univ Zurich Inst Mol Canc Res CH-8057 Zurich Switzerland;

    Univ Zurich Inst Mol Canc Res CH-8057 Zurich Switzerland;

    Netherlands Canc Inst Div Tumor Biol &

    Immunol NL-1066 CX Amsterdam Netherlands;

    Vanderbilt Univ Sch Med Dept Biochem Nashville TN 37205 USA;

    Columbia Univ Irving Med Ctr Irving Canc Res Dept Genet &

    Dev New York NY 10032 USA;

    Univ Zurich Inst Mol Canc Res CH-8057 Zurich Switzerland;

    Univ Zurich Inst Mol Canc Res CH-8057 Zurich Switzerland;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 细胞生物学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号